Literature DB >> 31776280

Breaking the Convention: Sialoglycan Variants, Coreceptors, and Alternative Receptors for Influenza A Virus Entry.

Umut Karakus1, Marie O Pohl1, Silke Stertz2.   

Abstract

The influenza A virus (IAV) envelope protein hemagglutinin binds α2,6- or α2,3-linked sialic acid as a host cell receptor. Bat IAV subtypes H17N10 and H18N11 form an exception to this rule and do not bind sialic acid but enter cells via major histocompatibility complex (MHC) class II. Here, we review current knowledge on IAV receptors with a focus on sialoglycan variants, protein coreceptors, and alternative receptors that impact IAV attachment and internalization beyond the well-described sialic acid binding.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  influenza virus; receptor; viral entry

Mesh：

Substances：

Year:  2020        PMID： 31776280      PMCID： PMC6997770          DOI： 10.1128/JVI.01357-19

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  83 in total

1.  Mucins and mucoids in relation to influenza virus action; inhibition of virus haemagglutination by glandular mucins.

Authors:  F M BURNET
Journal:  Aust J Exp Biol Med Sci       Date:  1948-09

2.  Chemical and immunochemical properties of two classes of globoside from equine organs.

Authors:  M Naiki
Journal:  Jpn J Exp Med       Date:  1971-02

3.  Hemagglutinins from two influenza virus variants bind to sialic acid derivatives with millimolar dissociation constants: a 500-MHz proton nuclear magnetic resonance study.

Authors:  N K Sauter; M D Bednarski; B A Wurzburg; J E Hanson; G M Whitesides; J J Skehel; D C Wiley
Journal:  Biochemistry       Date:  1989-10-17       Impact factor: 3.162

4.  Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin.

Authors:  Aarthi Chandrasekaran; Aravind Srinivasan; Rahul Raman; Karthik Viswanathan; S Raguram; Terrence M Tumpey; V Sasisekharan; Ram Sasisekharan
Journal:  Nat Biotechnol       Date:  2008-01-06       Impact factor: 54.908

5.  Novel roles of focal adhesion kinase in cytoplasmic entry and replication of influenza A viruses.

Authors:  Husni Elbahesh; Troy Cline; Tatiana Baranovich; Elena A Govorkova; Stacey Schultz-Cherry; Charles J Russell
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

6.  MHC class II proteins mediate cross-species entry of bat influenza viruses.

Authors:  Umut Karakus; Thiprampai Thamamongood; Martin Schwemmle; Silke Stertz; Kevin Ciminski; Wei Ran; Sira C Günther; Marie O Pohl; Davide Eletto; Csaba Jeney; Donata Hoffmann; Sven Reiche; Jan Schinköthe; Reiner Ulrich; Julius Wiener; Michael G B Hayes; Max W Chang; Annika Hunziker; Emilio Yángüez; Teresa Aydillo; Florian Krammer; Josua Oderbolz; Matthias Meier; Annette Oxenius; Anne Halenius; Gert Zimmer; Christopher Benner; Benjamin G Hale; Adolfo García-Sastre; Martin Beer
Journal:  Nature       Date:  2019-02-20       Impact factor: 49.962

Review 7.  The Interplay between the Host Receptor and Influenza Virus Hemagglutinin and Neuraminidase.

Authors:  Lauren Byrd-Leotis; Richard D Cummings; David A Steinhauer
Journal:  Int J Mol Sci       Date:  2017-07-17       Impact factor: 5.923

8.  The Hemagglutinin of Bat-Associated Influenza Viruses Is Activated by TMPRSS2 for pH-Dependent Entry into Bat but Not Human Cells.

Authors:  Markus Hoffmann; Nadine Krüger; Pawel Zmora; Florian Wrensch; Georg Herrler; Stefan Pöhlmann
Journal:  PLoS One       Date:  2016-03-30       Impact factor: 3.240

9.  Protection against influenza infection requires early recognition by inflammatory dendritic cells through C-type lectin receptor SIGN-R1.

Authors:  Miguel Palomino-Segura; Laurent Perez; Yagmur Farsakoglu; Tommaso Virgilio; Irene Latino; Rocco D'Antuono; Nikolaos Chatziandreou; Diego U Pizzagalli; Guojun Wang; Adolfo García-Sastre; Federica Sallusto; Michael C Carroll; Olivier Neyrolles; Santiago F Gonzalez
Journal:  Nat Microbiol       Date:  2019-07-29       Impact factor: 17.745

10.  DC-SIGN mediates avian H5N1 influenza virus infection in cis and in trans.

Authors:  Sheng-Fan Wang; Jason C Huang; Yuan-Ming Lee; Shih-Jen Liu; Yu-Jiun Chan; Yat-Pang Chau; Pele Chong; Yi-Ming Arthur Chen
Journal:  Biochem Biophys Res Commun       Date:  2008-06-30       Impact factor: 3.575
View more
  10 in total

1.  Influenza A Virus Agnostic Receptor Tropism Revealed Using a Novel Biological System with Terminal Sialic Acid Knockout Cells.

Authors:  Haruhiko Kamiki; Shin Murakami; Takashi Nishikaze; Takahiro Hiono; Manabu Igarashi; Yuki Furuse; Hiromichi Matsugo; Hiroho Ishida; Misa Katayama; Wataru Sekine; Yasushi Muraki; Masateru Takahashi; Akiko Takenaka-Uema; Taisuke Horimoto
Journal:  J Virol       Date:  2022-07-18       Impact factor: 6.549

Review 2.  Nanomedicine based approaches for combating viral infections.

Authors:  Saurabh Shah; Mahavir Bhupal Chougule; Arun K Kotha; Rama Kashikar; Chandraiah Godugu; Rajeev Singh Raghuvanshi; Shashi Bala Singh; Saurabh Srivastava
Journal:  J Control Release       Date:  2021-08-08       Impact factor: 11.467

Review 3.  Roles of Glycans and Non-glycans on the Epithelium and in the Immune System in H1-H18 Influenza A Virus Infections.

Authors:  Nongluk Sriwilaijaroen; Yasuo Suzuki
Journal:  Methods Mol Biol       Date:  2022

4.  Andrographolide induces anti-SARS-CoV-2 response through host-directed mechanism: an in silico study.

Authors:  Bhabani Shankar Das; Nabarun Chandra Das; Shasank Sekhar Swain; Suprabhat Mukherjee; Debapriya Bhattacharya
Journal:  Future Virol       Date:  2022-07-04       Impact factor: 3.015

5.  Changes in sialic acid binding associated with egg adaptation decrease live attenuated influenza virus replication in human nasal epithelial cell cultures.

Authors:  Harrison Powell; Hsuan Liu; Andrew Pekosz
Journal:  Vaccine       Date:  2021-05-11       Impact factor: 4.169

6.  In silico docking analysis revealed the potential of phytochemicals present in Phyllanthus amarus and Andrographis paniculata, used in Ayurveda medicine in inhibiting SARS-CoV-2.

Authors:  Shridhar Hiremath; H D Vinay Kumar; M Nandan; M Mantesh; K S Shankarappa; V Venkataravanappa; C R Jahir Basha; C N Lakshminarayana Reddy
Journal:  3 Biotech       Date:  2021-01-11       Impact factor: 2.406

Review 7.  Application of Super-Resolution and Advanced Quantitative Microscopy to the Spatio-Temporal Analysis of Influenza Virus Replication.

Authors:  Emma Touizer; Christian Sieben; Ricardo Henriques; Mark Marsh; Romain F Laine
Journal:  Viruses       Date:  2021-02-02       Impact factor: 5.048

Review 8.  Emerging importance of nanotechnology-based approaches to control the COVID-19 pandemic; focus on nanomedicine iterance in diagnosis and treatment of COVID-19 patients.

Authors:  Behnam Hashemi; Firouzi-Amandi Akram; Halimeh Amirazad; Mehdi Dadashpour; Milad Sheervalilou; Davood Nasrabadi; Majid Ahmadi; Roghayeh Sheervalilou; Mahdieh Ameri Shah Reza; Farhood Ghazi; Leila Roshangar
Journal:  J Drug Deliv Sci Technol       Date:  2021-11-06       Impact factor: 3.981

9.  Human-type sialic acid receptors contribute to avian influenza A virus binding and entry by hetero-multivalent interactions.

Authors:  Mengying Liu; Liane Z X Huang; Anthony A Smits; Christian Büll; Yoshiki Narimatsu; Frank J M van Kuppeveld; Henrik Clausen; Cornelis A M de Haan; Erik de Vries
Journal:  Nat Commun       Date:  2022-07-13       Impact factor: 17.694

10.  Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.

Authors:  Ying Shao; Jason Saredy; Keman Xu; Yu Sun; Fatma Saaoud; Charles Drummer; Yifan Lu; Jin J Luo; Jahaira Lopez-Pastrana; Eric T Choi; Xiaohua Jiang; Hong Wang; Xiaofeng Yang
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.